Safety and Efficacy of Ranibizumab in Diabetic Macular Edema
Clinical trial NCT01131585 · TERMINATED
Trial details
- NCT number
- NCT01131585
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-06-01
- Primary completion
- 2011-07-01
- Enrollment
- 128
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.